Tan Kevin — SEC Form 4 filings
SEC reporting owner CIK 1884056. 11 Form 4 filings on record with FilingPulse; latest filed 2026-04-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-11 to 2026-04-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 63,900 shares, $390,153 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 26,837 shares @ $6.44 ($172,747) in Solid Biosciences Inc., filed 2026-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | CFO & Treasurer | 11 | — | 7 legs · 63,900 sh · $390,153 | 22 |
Form 4 filings — Tan Kevin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-21 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 56,647 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 10,625 · Sale (S): 5,404 @ $5.82 · Option exercise (M): 10,625 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Solid Biosciences Inc. (SLDB) | Sale (S): 14,783 @ $6.44 | EDGAR |
| 2026-02-02 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 56,646 · Option exercise (M): 33,075 · Sale (S): 26,837 @ $6.44 · Option exercise (M): 56,646 (derivative) @ $0 · Grant/award (A): 187,000 (derivative) @ $0 · Grant/award (A): 93,500 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-13 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 11,250 · Sale (S): 5,704 @ $5.27 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2025-08-18 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 10,625 · Sale (S): 3,164 @ $3.96 · Option exercise (M): 10,625 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 132,300 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 11,250 · Sale (S): 4,073 @ $3.89 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 85,000 (derivative) @ $0 · Grant/award (A): 42,500 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 11,250 · Sale (S): 3,935 @ $8.20 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1884056 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →